Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
PREM14A

A preliminary proxy statement relating to a merger or acquisition

Mergers & Acquisitions
SC 13D/A

An amendment to a SC 13D filing

3,4,5
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
4/A

Amendment to a previously filed 4

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5